Variant report
Variant | nsv977723 |
---|---|
Chromosome Location | chr15:60162970-60165564 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555611137 | chr15:60164267-60164268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573965760 | chr15:60164295-60164296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541109451 | chr15:60164301-60164302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559994898 | chr15:60164325-60164326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533401263 | chr15:60164336-60164337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545306137 | chr15:60164343-60164344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563506511 | chr15:60164356-60164357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531032947 | chr15:60164358-60164359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549832218 | chr15:60164366-60164367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568103591 | chr15:60164390-60164391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374509625 | chr15:60164395-60164396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367800943 | chr15:60164431-60164432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112728356 | chr15:60164432-60164433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75936077 | chr15:60164433-60164434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142044003 | chr15:60164449-60164450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189838470 | chr15:60164450-60164451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17237089 | chr15:60164489-60164490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs574184923 | chr15:60164490-60164491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528367503 | chr15:60164518-60164519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569842998 | chr15:60164519-60164520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7164737 | chr15:60164530-60164531 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs536885772 | chr15:60164537-60164538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62015005 | chr15:60164538-60164539 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs372464737 | chr15:60164541-60164542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532100456 | chr15:60164597-60164598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200359648 | chr15:60164607-60164608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574098953 | chr15:60164617-60164618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541521246 | chr15:60164622-60164623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112935624 | chr15:60164625-60164626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148570143 | chr15:60164626-60164627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577632764 | chr15:60164674-60164675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144263097 | chr15:60164700-60164701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377536540 | chr15:60164701-60164702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376966063 | chr15:60164714-60164715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545788395 | chr15:60164720-60164721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147379646 | chr15:60164721-60164722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372515833 | chr15:60164732-60164733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530998700 | chr15:60164744-60164745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75703987 | chr15:60164771-60164772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561533921 | chr15:60164799-60164800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559553143 | chr15:60164800-60164801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528939430 | chr15:60164835-60164836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547483074 | chr15:60164880-60164881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565649095 | chr15:60164885-60164886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532982850 | chr15:60164907-60164908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551687495 | chr15:60164920-60164921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570008495 | chr15:60164922-60164923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370754481 | chr15:60164940-60164941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372934931 | chr15:60164979-60164980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555227379 | chr15:60164987-60164988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Mental retardation | 17124404 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:60164200-60167000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr15:60165000-60166800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |